Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis
Desirée Gavhed(Karolinska University Hospital), Jan‐Inge Henter(Karolinska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Selma Olsson Åkefeldt(Karolinska University Hospital), Lars Hjorth(Lund University), Gustaf Österlundh(University of Gothenburg), Evaldas Laurenčikas(Karolinska Institutet), Lars Rosengren(Sahlgrenska University Hospital)
Cited by 28
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k